Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Circulation. 2003;108:971-976
Published online before print August 11, 2003, doi: 10.1161/01.CIR.0000085070.39873.B1
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
108/8/971    most recent
01.CIR.0000085070.39873.B1v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hryniewicz, K.
Right arrow Articles by Katz, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hryniewicz, K.
Right arrow Articles by Katz, S. D.
Related Collections
Right arrow Cardio-renal physiology/pathophysiology
Right arrow Congestive
Right arrow Cardiovascular Pharmacology
Right arrow Autonomic, reflex, and neurohumoral control of circulation

(Circulation. 2003;108:971.)
© 2003 American Heart Association, Inc.

Clinical Investigation and Reports

Comparative Effects of Carvedilol and Metoprolol on Regional Vascular Responses to Adrenergic Stimuli in Normal Subjects and Patients With Chronic Heart Failure

Katarzyna Hryniewicz, MD; Ana Silvia Androne, MD; Alhakam Hudaihed, MD; Stuart D. Katz, MD

From the Department of Medicine, Columbia University College of Physicians & Surgeons, New York, NY, and Department of Internal Medicine, Yale University College of Medicine, New Haven, Conn.

Correspondence to Stuart D. Katz, MD, Yale University School of Medicine, 135 College St, Suite 301, New Haven, CT 06510. E-mail stuart.katz{at}yale.edu

Received October 3, 2002; de novo received February 28, 2003; accepted May 21, 2003.

Background— Adrenergic receptor blockers used in the treatment of heart failure have distinct receptor affinity profiles. We hypothesized that {alpha}-adrenergic–blocking effects of carvedilol would limit vasoconstriction in response to adrenergic stimuli when compared with metoprolol.

Methods and Results— Forearm vascular resistance responses to isometric handgrip and cold pressor test were determined by plethysmography before and during adrenergic receptor blockade in prospective randomized trials. Acute effects were assessed in a crossover trial in normal subjects (single dose of 25 mg carvedilol, 100 mg metoprolol tartrate, and placebo). Chronic effects (25 mg carvedilol BID versus 200 mg extended-release metoprolol succinate daily for 6 months) were assessed in a parallel group trial of chronic heart failure subjects. In normal subjects, carvedilol decreased forearm vascular resistance responses to adrenergic stimuli when compared with metoprolol and placebo (isometric handgrip -3.5 U for carvedilol versus -1.2 U for metoprolol and -2.2 U for placebo, P=0.15; cold pressor test 3.1±8.9 U for carvedilol versus 9.0±2.7 U for metoprolol and 8.2±5.8 U for placebo, P<0.05). In heart failure subjects, vasomotor responses to isometric handgrip and cold pressor test did not differ between treatment groups.

Conclusions— Acute administration of carvedilol attenuates the vasoconstriction response to adrenergic stimuli when compared with placebo and metoprolol in normal subjects, whereas chronic administration of carvedilol does not attenuate the vasoconstrictor response to adrenergic stimuli when compared with metoprolol in heart failure subjects. These data suggest that long-term benefits of carvedilol in heart failure are not mediated by {alpha}-adrenergic blockade.


Key Words: heart failure • nervous system, sympathetic • vasoconstriction • pharmacology • blood flow




This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
E. A. Woodcock, X.-J. Du, M. E. Reichelt, and R. M. Graham
Cardiac {alpha}1-adrenergic drive in pathological remodelling
Cardiovasc Res, February 1, 2008; 77(3): 452 - 462.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
L. A. Nikolaidis, I. Poornima, P. Parikh, M. Magovern, Y.-T. Shen, and R. P. Shannon
The Effects of Combined Versus Selective Adrenergic Blockade on Left Ventricular and Systemic Hemodynamics, Myocardial Substrate Preference, and Regional Perfusion in Conscious Dogs With Dilated Cardiomyopathy
J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1871 - 1881.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
T.-a. Koshimizu, G. Tsujimoto, A. Hirasawa, Y. Kitagawa, and A. Tanoue
Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human {alpha}1D- and {alpha}1B-adrenergic receptors
Cardiovasc Res, September 1, 2004; 63(4): 662 - 672.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. Kindermann, C. Maack, S. Schaller, N. Finkler, K. I. Schmidt, S. Laer, H. Wuttke, H.-J. Schafers, and M. Bohm
Carvedilol but Not Metoprolol Reduces {beta}-Adrenergic Responsiveness After Complete Elimination From Plasma In Vivo
Circulation, June 29, 2004; 109(25): 3182 - 3190.
[Abstract] [Full Text] [PDF]

Home page
 J CARDIOVASC PHARMACOL THERHome page
J. L. Bauman and R. L. Talbert
Pharmacodynamics of{beta}-Blockers in Heart Failure: Lessons from the Carvedilol Or Metoprolol European Trial
Journal of Cardiovascular Pharmacology and Therapeutics, April 1, 2004; 9(2): 117 - 128.
[Abstract] [PDF]


Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.